Tenax Therapeutics Inc (TENX)
3.50
-0.06
(-1.69%)
USD |
NASDAQ |
Apr 23, 16:00
3.53
+0.03
(+0.86%)
After-Hours: 20:00
Tenax Therapeutics Free Cash Flow (Quarterly): -1.174M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.174M |
| September 30, 2023 | -2.081M |
| June 30, 2023 | -0.923M |
| March 31, 2023 | -1.725M |
| December 31, 2022 | -1.685M |
| September 30, 2022 | -3.331M |
| June 30, 2022 | -3.431M |
| March 31, 2022 | -2.944M |
| December 31, 2021 | -2.770M |
| September 30, 2021 | -3.023M |
| June 30, 2021 | -1.847M |
| March 31, 2021 | -3.221M |
| December 31, 2020 | -1.987M |
| September 30, 2020 | -2.385M |
| June 30, 2020 | -2.229M |
| March 31, 2020 | -2.671M |
| December 31, 2019 | -1.726M |
| September 30, 2019 | -1.782M |
| June 30, 2019 | -1.915M |
| March 31, 2019 | -2.136M |
| December 31, 2018 | -1.199M |
| September 30, 2018 | -1.556M |
| June 30, 2018 | -1.190M |
| March 31, 2018 | -1.562M |
| December 31, 2017 | -1.282M |
| Date | Value |
|---|---|
| September 30, 2017 | -1.227M |
| June 30, 2017 | -5.595M |
| March 31, 2017 | -4.041M |
| December 31, 2016 | -3.105M |
| September 30, 2016 | -4.281M |
| June 30, 2016 | -5.166M |
| March 31, 2016 | -3.323M |
| October 31, 2015 | -2.702M |
| September 30, 2015 | |
| July 31, 2015 | -3.860M |
| April 30, 2015 | -1.642M |
| March 31, 2015 | -2.558M |
| January 31, 2015 | -3.257M |
| October 31, 2014 | -2.962M |
| July 31, 2014 | -1.998M |
| April 30, 2014 | -3.014M |
| January 31, 2014 | -2.750M |
| October 31, 2013 | -2.049M |
| July 31, 2013 | -1.596M |
| April 30, 2013 | -1.487M |
| January 31, 2013 | -0.7742M |
| October 31, 2012 | -1.166M |
| July 31, 2012 | -1.647M |
| April 30, 2012 | -1.479M |
| January 31, 2012 | -2.320M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-3.431M
Minimum
Jun 2022
-0.923M
Maximum
Jun 2023
-2.255M
Average
-2.081M
Median
Sep 2023
Free Cash Flow (Quarterly) Benchmarks
| BioRestorative Therapies Inc | -1.844M |
| Immunome Inc | -17.81M |
| Jasper Therapeutics Inc | -16.71M |
| Cadrenal Therapeutics Inc | -0.6944M |
| GE HealthCare Technologies Inc | 956.00M |